We have a trial already with a checkpoint inhibitor which is a type of immunotherapy cancer vaccine.

The trial is in combination partnership with Keytruda (pembrolizumab) in a breast cancer xenograft model.

When Jay spoke it was pretty clear that a paper should come out soon on this trial. Someone correct me if I’m wrong but this is what I gathered when he talked about publishing papers.

Cancer news in this area would be huge. The result should be complete and the results are most likely being published very soon.


https://www.biospace.com/article/embattled-cy...h-tumors-/